Here are five things to know about him.
1. Dr. Gross will serve as the primary investigator on the company’s Reduce study. The study will examine the effectiveness of its Pure-Vu System for inpatient colonoscopies. The Pure-Vu System is an alternative method of colonoscopy preparation.
2. Dr. Gross has 17-plus years of gastroenterology experience.
3. He currently serves as an associate professor of medicine at New York City-based NYU School of Medicine.
4. Dr Gross earned his medical degree at Tel Aviv, Israel-based Tel Aviv University. He completed a residency at Evanston, Ill.-based Northshore University Hospital and a fellowship at Rochester, Minn.-based Mayo Clinic.
5. He said, “I believe the Pure-Vu System offers a powerful new tool to address [colonoscopy prep] challenges and potentially provides a more consistent, effective procedure. I look forward to working with the Motus GI medical advisory board as we look to advance the Pure-Vu System.”
More articles on gastroenterology:
DOJ cracks down on health system performing outpatient surgeries as inpatient; Banner Health to pay $18M+ settlement: 5 things to know
ASCA Foundation to fund One World Surgery medical mission scholarships: 4 things to know
ASC supply chain tip of the day: track costs for better business management
